Disappointment across US after CBD language dropped from omnibus bill

CBD stakeholders hoping for clarity in US regulations were left disappointed by the passing of the $1.5tn omnibus spending bill earlier this month as some helpful language was dropped during the final negotiations.

Originally the US Senate Appropriations Committee incorporated sought-after language in its Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Appropriations Bill that would eventually form part of the so-called omnibus bill.

The language in the Senate’s version included a directive instructing the US Food and Drug Administration (FDA) to publish a policy outlining enforcement discretion, within 90 days of the bill becoming law. This would have brought clarity to the market and been welcomed by all sectors.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Pablo Sharrock
+34 722 642 678
Email Pablo